Your browser doesn't support javascript.
loading
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers.
Zhang, Zhen; Wu, Hao-Xiang; Lin, Wu-Hao; Wang, Zi-Xian; Yang, Lu-Ping; Zeng, Zhao-Lei; Luo, Hui-Yan.
Afiliação
  • Zhang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.
  • Wu HX; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, People's Republic of China.
  • Lin WH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.
  • Wang ZX; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, People's Republic of China.
  • Yang LP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.
  • Zeng ZL; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, 510060, People's Republic of China.
  • Luo HY; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.
BMC Med ; 19(1): 26, 2021 02 02.
Article em En | MEDLINE | ID: mdl-33526018

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphA7 / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphA7 / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article